Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Randomised Trial Investigating the Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC
Sponsor: Chinese University of Hong Kong
Summary
This is a prospective, multi-centre randomised trial comparing between cTURBT plus 1-year BCG therapy, and ERBT plus 1-year BCG therapy, in patients with intermediate-risk or high-risk NMIBC.
Official title: A Randomised Trial Investigating the Role of Transurethral En Bloc Resection of Bladder Tumour Plus Intravesical Bacillus Calmette-Guerin Therapy, in Patients With Intermediate-Risk or High-Risk Non-Muscle-Invasive Bladder Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
732
Start Date
2026-07-01
Completion Date
2030-03-31
Last Updated
2026-07-24
Healthy Volunteers
No
Conditions
Interventions
Conventional Transurethral Resection of Bladder Tumour
Conventional TURBT is performed by resecting the bladder tumour in a piecemeal manner with a top-down approach. The bladder tumour specimen is fragmented during the procedure and whether a complete resection has been achieved is determined by the operating surgeon's judgment intra-operatively.
Transurethral En Bloc Resection of Bladder Tumour
This surgical technique resects the bladder tumour underneath the submucosal plane, and the bladder tumour can be removed in one piece.
Locations (2)
Prince of Wales Hospital
Hong Kong, Hong Kong
North District Hospital
Sheung Shui, Hong Kong